Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinji Urakami

Showing results (71-80 of 137) with videos related to

Pageof 14
Sort By:
Urology|February 15, 2011
Tumor size is a potential predictor of response to tyrosine kinase inhibitors in renal cell cancerTakeshi Yuasa, Shinji Urakami, Shinya Yamamoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detectionShinji Urakami, Hiroaki Shiina, Hideki Enokida, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|July 20, 2022
[A CASE OF FUMARATE HYDRATASE (FH)-DEFICIENT RENAL CELL CARCINOMA SUSPECTED OF HEREDITARY LEIOMYOMATOSIS RENAL CELL CARCINOMA]Kiichi Hagiwara, Shinji Urakami, Kazushige Sakaguchi, et al.
Anticancer Research|June 4, 2021
HLA-DR and CD74 Expression and the Immune Microenvironment in Renal Cell CarcinomaYuji Miura, Toshiki Anami, Junji Yatsuda, et al.
Urologic Oncology|April 9, 2013
Phase II trial of first-line chemotherapy with gemcitabine, etoposide, and cisplatin for patients with advanced urothelial carcinomaShinji Urakami, Yasuhisa Fujii, Shinya Yamamoto, et al.
Lower Urinary Tract Symptoms|September 26, 2018
Effect of tadalafil add-on therapy in patients with persistant storage symptoms refractory to α<sub>1</sub> -adrenoceptor antagonist monotherapy for benign prostatic hyperplasia: A randomized pilot trial comparing tadalafil and solifenacinShinji Urakami, Kohei Ogawa, Suguru Oka, et al.
World Journal of Urology|January 16, 2007
Functional improvement in spinal cord injury-induced neurogenic bladder by bladder augmentation using bladder acellular matrix graft in the ratShinji Urakami, Hiroaki Shiina, Hideki Enokida, et al.
Cancer Research|October 20, 2004
Blockade of paclitaxel-induced thymidine phosphorylase expression can accelerate apoptosis in human prostate cancer cellsNobuyuki Kikuno, Nobuko Moriyama-Gonda, Tateki Yoshino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNAShinji Urakami, Hiroaki Shiina, Hideki Enokida, et al.
Urology Case Reports|April 30, 2026
Solitary renal metastasis from salivary epithelial-myoepithelial carcinoma mimicking renal cell carcinoma: A case report of robot-assisted partial nephrectomySayo Daidoji, Eri Fukagawa, Shinji Ito, et al.
Pageof 14

Showing results (71-80 of 137) with videos related to

Sort By:
Pageof 14
Urology|February 15, 2011
Tumor size is a potential predictor of response to tyrosine kinase inhibitors in renal cell cancerTakeshi Yuasa, Shinji Urakami, Shinya Yamamoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detectionShinji Urakami, Hiroaki Shiina, Hideki Enokida, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|July 20, 2022
[A CASE OF FUMARATE HYDRATASE (FH)-DEFICIENT RENAL CELL CARCINOMA SUSPECTED OF HEREDITARY LEIOMYOMATOSIS RENAL CELL CARCINOMA]Kiichi Hagiwara, Shinji Urakami, Kazushige Sakaguchi, et al.
Anticancer Research|June 4, 2021
HLA-DR and CD74 Expression and the Immune Microenvironment in Renal Cell CarcinomaYuji Miura, Toshiki Anami, Junji Yatsuda, et al.
Urologic Oncology|April 9, 2013
Phase II trial of first-line chemotherapy with gemcitabine, etoposide, and cisplatin for patients with advanced urothelial carcinomaShinji Urakami, Yasuhisa Fujii, Shinya Yamamoto, et al.
Lower Urinary Tract Symptoms|September 26, 2018
Effect of tadalafil add-on therapy in patients with persistant storage symptoms refractory to α<sub>1</sub> -adrenoceptor antagonist monotherapy for benign prostatic hyperplasia: A randomized pilot trial comparing tadalafil and solifenacinShinji Urakami, Kohei Ogawa, Suguru Oka, et al.
World Journal of Urology|January 16, 2007
Functional improvement in spinal cord injury-induced neurogenic bladder by bladder augmentation using bladder acellular matrix graft in the ratShinji Urakami, Hiroaki Shiina, Hideki Enokida, et al.
Cancer Research|October 20, 2004
Blockade of paclitaxel-induced thymidine phosphorylase expression can accelerate apoptosis in human prostate cancer cellsNobuyuki Kikuno, Nobuko Moriyama-Gonda, Tateki Yoshino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNAShinji Urakami, Hiroaki Shiina, Hideki Enokida, et al.
Urology Case Reports|April 30, 2026
Solitary renal metastasis from salivary epithelial-myoepithelial carcinoma mimicking renal cell carcinoma: A case report of robot-assisted partial nephrectomySayo Daidoji, Eri Fukagawa, Shinji Ito, et al.
Pageof 14